The biotech-company EraCal Therapeutics Ltd. is a spin-off from the University of Zurich and Harvard University. The company is privately held by a biotech-specialized investor base incl. BERNINA BioInvest, Redalpine, and UZH Life Sciences Fund. The preclinical biotech-company EraCal Therapeutics Ltd. is a spin-off of the University of Zurich and Harvard University, and develops first-in-class drugs to treat different diseases...
The biotech-company EraCal Therapeutics Ltd. is a spin-off from the University of Zurich and Harvard University. The company is privately held by a biotech-specialized investor base incl. BERNINA BioInvest, Redalpine, and UZH Life Sciences Fund. The preclinical biotech-company EraCal Therapeutics Ltd. is a spin-off of the University of Zurich and Harvard University, and develops first-in-class drugs to treat different diseases.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.